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RLIP76 is an effector for Ral small GTPases, which in
turn lie downstream of the master regulator Ras.
Evidence is growing that Ral and RLIP76 play a role
in tumorigenesis, invasion, and metastasis. RLIP76
contains both a RhoGAP domain and a Ral binding
domain (GBD) and is, therefore, a node between
Ras and Rho family signaling. The structure of the
RhoGAP-GBD dyad reveals that the RLIP76 RhoGAP
domain adopts a canonical RhoGAP domain struc-
ture and that the linker between the two RLIP76 do-
mains is structured, fixing the orientation of the two
domains and allowing RLIP76 to interact with Rho-
family GTPases and Ral simultaneously. However,
the juxtaposed domains do not influence each other
functionally, suggesting that the RLIP76-Ral inter-
action controls cellular localization and that the
fixed orientation of the two domains orientates the
RhoGAP domain with respect to the membrane, al-
lowing it to be perfectly poised to engage its target
G proteins.
INTRODUCTION
The Ral interacting protein (RLIP76)/Ral binding protein (RalBP1)
is a downstream effector of the Ral GTPases, which themselves
lie downstream of the key regulator small G protein Ras. Acti-
vated Ras has the ability to initiate a cascade of signaling path-
ways due to its capacity to interact with several different groups
of effector proteins, the best studied of which are the Rafs, PI3
kinases, and RalGEFs. Despite the supreme ability of Ras to
transform cells, of all the Ras effector families, only the RalGEFs
can transform immortalized primary human fibroblasts, and this
activity requires Ral (Hamad et al., 2002). RalGEF and Ral are
also known to be critical for an aggressive, metastatic phenotype
in both 3T3 cells and bladder carcinoma cell lines (T24T) (Gildea
et al., 2002; Ward et al., 2001). Hence, the RalGEF/Ral pathway
is a potential target for the treatment of human cancers. The
components of the RalGEF pathway downstream of Ral thatStrumediate invasion and metastasis are starting to be elucidated.
As RLIP76 is one of the effector proteins of the Ral GTPases,
this makes it an important target to investigate, especially as
there is evidence to suggest that RLIP76 has a role to play in
cell motility (Coon et al., 2010) and that RalB and RLIP76 are
responsible for the formation of invadopodia (Neel et al., 2012).
RLIP76 is a multidomain, multifunctional protein that was first
identified for its ability to interact with activated Ral GTPases
(Jullien-Flores et al., 1995; Park and Weinberg, 1995; Cantor
et al., 1995). The Ral binding domain (GBD) of RLIP76 mediates
the interaction with RalA/B, utilizing a coiled coil to contact the
nucleotide-sensitive switch regions of the G protein (Fenwick
et al., 2010). Immediately N terminal to the GBD is a region ho-
mologous to the GTPase-activating protein (GAP) domains for
Rho GTPases, which has limited activity toward some members
of the Rho family of small GTPases that are known to regulate
actin cytoskeletal rearrangements and gene expression (Jul-
lien-Flores et al., 1995; Park and Weinberg, 1995; Cantor et al.,
1995). RLIP76 has also been linked to endocytosis and tyrosine
kinase receptor signaling via its ability to bind to AP2, REPS1/
REPS2 (POB1), and Epsin (Jullien-Flores et al., 2000; Yamaguchi
et al., 1997; Ikeda et al., 1998; Coon et al., 2010). It can therefore
be postulated that RLIP76 links Rho-family small G proteins to
the endocytic machinery. RLIP76 has been shown to be associ-
ated with the active Cdk1 complex and serves as a platform for
Cdk1 to phosphorylate Epsin and shut down endocytosis during
mitosis (Rosse´ et al., 2003). Our knowledge of the roles of RLIP76
and RalA in mitosis has been extended more recently, as both
proteins have been implicated in mitochondrial fission (Kashatus
et al., 2011): RalA phosphorylation by AuroraA leads to RalA and
RLIP76 localization to mitochondria and, once there, they regu-
late the phosphorylation of the Drp1 GTPase by Cdk1-CyclinB.
RLIP76 is usually located in the cytoplasm, but translocates to
the membrane upon activation by Ral proteins (Lim et al., 2010).
It contains two putative ATP binding sites (residues 65–80 and
415–448) (Awasthi et al., 2001), which allow membrane-associ-
ated RLIP76 to function as an ATP-dependent transporter pro-
tein that acts as an efflux pump for small molecules including
anticancer drugs and endogenous metabolites (Vatsyayan
et al., 2010). RLIP76 is overexpressed in metastatic bladder can-
cer (Smith et al., 2007), melanoma, lung carcinoma, and ovarian
carcinoma (reviewed in Vatsyayan et al., 2010) and is necessary
for metastasis of human pancreatic and bladder cancer cell linescture 21, 2131–2142, December 3, 2013 ª2013 The Authors 2131
Figure 1. Structure of the RLIP76 GAP-GBD Didomain
(A) The schematic domain structure of RLIP76 is shown above the closest structure to the mean. The limits of the construct whose structure is shown are outlined
in blue. In this and all subsequent figures, the RhoGAP domain is colored green, the linker between the domains is cyan, and the GBD is pink. The loop between
helices aF and aG is colored red.
(legend continued on next page)
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RLIP76 RhoGAP-Ral Binding Domain Dyad Structurein nude mice (Wu et al., 2010). RalB and RLIP76 together are
required for the formation of invadopodia in pancreatic ductal
adenocarcinoma (Neel et al., 2012). It has also been shown
that overexpression of the RLIP76 GBD in MDCK cells represses
the action of endogenous Ral proteins and that this repression
leads to cell-cycle arrest and loss of anchorage-independent
proliferation in human breast adenocarcinomas (Chien and
White, 2003).
Whether RLIP76 functions as a modular protein with indepen-
dent domains, so that each domain is free to interact with its own
interacting partner(s), or whether the domains interact among
themselves and regulate each other is currently unknown. As
the RhoGAP domain interacts with Rho-family small G proteins
and the GBD interacts with the Ral proteins, RLIP76 could act
as an intersection point for these distinct signaling pathways,
and juxtaposition of the GAP and GBD domains could be the
strategy employed by RLIP76 to coordinate regulation of both
pathways.
We have solved the structure of the RLIP76 GAP-GBD ‘‘dido-
main’’ with the aim of understanding any communication
between the juxtaposed domains. The GBD in the dyad retains
the same structure as the free GBD, and the RhoGAP domain
adopts the canonical RhoGAP conformation, allowing the identi-
fication of the crucial catalytic residues. However, as RLIP76
has very poor GAP activity, we have also investigated the cata-
lytic activity of the GAP domain and GAP-GBD didomain
in vitro. Unexpectedly, the structure shows that the linker
between the two domains is well defined and in a fixed confor-
mation, sandwiching the two domains together in a locked
configuration with respect to each other. Despite this, we find
no evidence that either domain influences the functional activity
of the other, and suggest rather that Ral binding to the RLIP76
GBD serves to localize RLIP76 to the correct cellular membrane
and simultaneously fixes the orientation of the RLIP76 RhoGAP
domain relative to that membrane, such that it is perfectly posi-
tioned to engage its Rho-family substrate, which will be tethered
at the same location.
RESULTS
Structure of the RLIP76 GAP-GBD Didomain
The resonances of the GAP-GBD didomain (residues 184–446)
were assigned as reported elsewhere (Rajasekar et al., 2012).(B) The 35 lowest-energy structures calculated of the RLIP76 didomain.
(C) Summary of the assigned distance restraints between the N-terminal half of th
atoms connected by orange dashed lines. For clarity, only a single restraint for eac
the linker are shown as black dashed lines.
(D) Summary of the assigned distance restraints between the hairpin of the link
between the linker and the GBD for the atoms connected by orange dashed lines
atoms, shown as green dashed lines. For clarity, only a single restraint for each
(E) Comparison of the p50 RhoGAP-Cdc42 complex and the RLIP76 GAP doma
shown in a wire-frame representation, the Mg2+ ion is pink, and BeF3 is shown i
secondary lysine are oriented correctly in the RLIP76 GAP domain to aid catalysis
are oriented in the same direction in both RLIP76 and the p50 RhoGAP-Cdc42 tra
so that it can support the position of the arginine finger loop in a similar manner
(F) The loop between helices aF and aG is truncated in the RLIP76 GAP domain. T
two helices. In the complex formed betweenCdc42$GMPPNP (purple) and p50 Rh
The only contact that remains is at the beginning of the aG helix, where Asn414
RLIP76 is Asn354, but this is not sufficient for a high-affinity interaction. The resid
stick representation.
StruThe final ensemble of structures was calculated from a total of
8,551 nuclear Overhauser effect (NOE) restraints, which were
translated by ARIA into 4,748 unambiguous and 2,272 ambig-
uous unique restraints. Except for part of the loop region that
connects the two domains, the structure is well defined (Figures
1A and 1B), with a root-mean-square deviation (rmsd) of 0.76 A˚
(Table 1).
The GAP domain (residues 184–368) is formed by nine a heli-
ces arranged in a typical RhoGAP fold (Barrett et al., 1997;
Rittinger et al., 1997), usually named aA0, aA, aA1, and aB-aG
(Figure 2). The core of the domain is formed by helices A, B, E,
and F, which form a four-helical bundle. Helices C and D sand-
wich helix G onto the face of helices E and F, and helix A1 packs
against helices A and B. The conserved arginine ‘‘finger,’’
Arg232, is present in the loop between helices A and A1. The
secondary lysine, Lys268, which stabilizes the position of the
finger loop, is within helix B. Comparison of the RLIP76 GAP
domain structure with the canonical RhoGAP shows that the
orientation of the a helices is conserved, with an rmsd of
1.5 A˚ when the helical regions are overlaid.
The GBD (residues 393–446) in the didomain is a coiled coil,
which is similar to the structure that we previously observed
both in isolation and in complex with RalB (Fenwick et al., 2010).
The backbone rmsd between the two GBD a helices in this struc-
ture and in the RalB complex (Protein Data Bank [PDB] ID code
2KWI) is 1.0 A˚. Thus, the overall architecture of the G protein
binding domain is preserved in the longer construct. This is in
agreement with our observations that the GAP-GBD didomain
and the GBD single domain bind to RalB with the same affinity
of 200 nM (Fenwick et al., 2010 and data not shown).
The orientation of the two single domains that make up the
GAP-GBD didomain is well defined in the family of structures
due to a number of distance restraints observed between each
domain and the linker that connects them. The final a helix of
the canonical RhoGAP domain finishes at Phe368, and the
next nine residues (Gly369–Met377) contact the surface of the
GAP domain comprising helices aE and aA and the linker
between aA0 and aA (Figure 1C). Several of the residues
involved in these interactions are hydrophobic and not
conserved in the other RhoGAP proteins, for example, Met203,
Ile207, and Val323, which are absent, Glu257, and Ala372,
respectively, in p50 RhoGAP (Figure 2). Met377 also interacts
with two exposed hydrophobic residues in the N-terminal a helixe linker and the RhoGAP-GBD. Distance restraints were observed between the
h residue pair is shown. Contacts between Asp218 and Lys222 in helix aA and
er and GBD and within the linker hairpin. Distance restraints were observed
. The hairpin in the linker is defined by a number of distance restraints between
pair of residues is shown.
in. Cdc42 is purple, RLIP76 GAP is green, and p50 RhoGAP is orange. GDP is
n a ball-and-stick representation. The arginine finger at the active site and the
. The positions of Arg232RLIP76 and Arg282p50 are the same, and the side chains
nsition-state complex (PDB ID code 1GRN). Similarly, Lys268RLIP76 is oriented
to Lys319p50.
he RLIP76 GAP domain (in green) has a shorter loop (shown in red) between the
oGAP (orange), several contacts aremade by the longer loop (shown in yellow).
in p50 RhoGAP makes a hydrogen bond with Tyr64. The equivalent residue in
ues involved in interactions between Cdc42 and p50 RhoGAP are shown in a
cture 21, 2131–2142, December 3, 2013 ª2013 The Authors 2133
Table 1. Structural Statistics for the RLIP76 GAP-GBD Didomain
Experimental Restraints Used in Structure Calculation
Unambiguous NOEs 4,748
Ambiguous NOEs 2,272
Dihedral angle restraints (f + c) 472
Hydrogen bonds 118
PRE distance restraints 130
RDCs (phage) 141
GAP to linker NOEs 73
GAP to GBD NOEs 3
Linker to GBD NOEs 23
Intralinker NOEs (nonsequential) 33
Structural Statistics
Coordinate precision (A˚) <SA>a <SA>c
b
RMSD of backbone atoms
GAP-GBD didomain 190–444 (A˚) 0.76 0.50
GAP domain 190–380 (A˚) 0.56 0.40
GBD 395–444 (A˚) 0.43 0.32
Rmsd of heavy atoms
GAP-GBD didomain 190–444 (A˚) 1.20 0.98
GAP 190–380 (A˚) 1.02 0.89
GBD 395–444 (A˚) 1.01 0.98
RMS deviations
From experimental restraints
All NOE distances (A˚) 0.024 ± 0.0029 0.028
PRE distances (A˚) 0.009 ± 0.0053 0.013
GAP to linker NOEs (A˚) 0.022 ± 0.0056 0.021
GAP to GBD NOEs (A˚) 0.051 ± 0.029 0.000
Linker to GBD NOEs (A˚) 0.029 ± 0.011 0.041
Intralinker NOEs (A˚) 0.031 ± 0.0099 0.036
Dihedral angles (o) 1.06 ± 011 0.969
RDC Q factor 0.242 ± 0.013c 0.242c
From idealized geometry
Bonds (A˚) 0.0039 ± 5.3 3 105 0.0038
Angles (o) 0.578 ± 0.011 0.558
Impropers (o) 1.53 ± 0.059 1.44
Ramachandran analysisd
Most favored regions (%) 86 86.3
Allowed regions (%) 11.5 12.0
Generously allowed regions (%) 1.9 0.8
Disallowed regions (%) 0.6 0.8
a<SA> is the average rms deviation for the ensemble ± the standard de-
viation.
b<SA>c is the value for the structure that is closest to the mean.
cCalculated using PALES (Zweckstetter, 2008):
Q=
nXN
i =1

dnormi ðexpÞ  dnormi ðcalcÞ
2
=N
o1 =
2
=Dr:m:s:;
where Dr.m.s. was calculated from the experimental couplings.
dPROCHECK (Laskowski et al., 1993).
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the linker that reverses the chain and brings it back toward the
GBD (Figure 1D). The residues in the center of this hairpin are
flexible and the backbone amides of residues 383, 384, and
385 could not be assigned, implying that they are undergoing
dynamic changes on a millisecond timescale. The ends of the
hairpin are buttressed against the GBD by interactions between
Trp382 and Met388 in the linker and Ile435 and Ala438 in the
C-terminal helix of the GBD. The hairpin itself is defined by mul-
tiple distance restraints, for example, from Trp382 and Ser383 to
Met385, Ala386, Thr387, andMet388. The remainder of the linker
is pinned against the GBD by interactions between Leu391 and
Ala438 and Leu439 in the GBD.
There are few distance restraints between the two domains
because theydonot forma largeburied surfaceareaat their inter-
face, and indeed only come together where Met377 in the linker
acts as a hasp between the GAP and the N-terminal a helix of
theGBD.Met377contactsTyr204,which is sandwichedbetween
Phe407 and Leu408, and distance restraints between Met377
and Phe407 reinforce the contacts (Figure 1C). Long-range
data from paramagnetic relaxation enhancement (PRE) experi-
ments support the location of the contacts between the domains:
attachment of a spin label to Cys411 in the GBD leads to com-
plete bleaching of residues in helix aA0 and in the aA0-aA loop.
The RLIP76 GAP Domain Displays Weak GAP Activity
toward Cdc42 and Rac1
The GAP activity of the RLIP76 GAP domain and the RLIP76
didomain were determined in vitro using a real-time GAP assay.
Wild-typeRac1 andCdc42were preloadedwithGTP, and the hy-
drolysis of the nucleotide bound to the G protein was measured
by assaying for the phosphate released (Figure 3; Table 2). The
intrinsic rates of GTP hydrolysis measured for Rac1 and Cdc42
were 0.097 and 0.148min1, respectively, similar to values previ-
ously obtained by real-time experiments (Zhang et al., 1997,
1998). Addition of the bona fide GAP domain from p50 RhoGAP
at low levels (25 nM) stimulated the GTPase activity of both
Cdc42 and Rac1, as expected. Addition of the RLIP76 RhoGAP
domain at the same concentrations had no discernible effect
on the GTP hydrolysis rate of either Rac1 or Cdc42 (data not
shown), but when RLIP76 was added at higher concentrations,
such as 2.5 mM, stimulation of the GTPase activity could be
observed (Figure 3).Overall, the ability of theRLIP76GAPdomain
to stimulate the GTPase activity of Cdc42 and Rac1 is >100-
fold less efficient than the stimulatory effect of p50 RhoGAP.
To test the possibility that the juxtaposed GBD was necessary
for efficient GAP activity, we also performed GAP assays using
the GAP-GBD didomain at 2.5 mM and compared its activity
toward Rac1 and Cdc42. There was no increase in the activity
with the didomain when compared to the GAP domain alone.
Indeed, there is a small but reproducible decrease in the stimu-
lation of GTP hydrolysis by the didomain (Table 2). Addition of
stoichiometric quantities of GMPPNP-loaded RalB had no effect
on the GAP activity of the didomain (data not shown), in line with
previous work on RLIP76 (Jullien-Flores et al., 1995; Park and
Weinberg, 1995; Cantor et al., 1995).
Thus, although the Rho family GAP domain in RLIP76 can be
identified by sequence homology, we have shown that its stimu-
lation of hydrolysis by Rac1 and Cdc42 is significantly weakers
OCRL_2QV2 
p85alpha_1PBW 
p85beta_2XS6 
RhoGAP35_3FK2 
ARHGAP11A_3EAP 
GRAF_BH_1F7C
RhoGAP5_2EE4 
DLC1_3KUQ 
RICS_3IUG 
p50RhoGAP_1RGP
RLIP_188-368 
S C F G T S L E A L C R M K R P E R P L Q V P K E I W L L V D H L F K Y A C H Q E D L F Q
A L T L P D L A E Q F . . . . . A P P D I A P P L L I K L V E A I E K K G L E C S T L Y R
G L T L P D L P E Q F . . . . . S P P D V A P P L L V K L V E A I E R T G L D S E S H Y R
N Y F G V P L T T V V T . . . . . P E K P I P I F I E R C I E Y I E A T G L S T E G I Y R
K I F G V P F N A L P H S A V . P E Y G H I P S F L V D A C T S L E D . H I H T E G L F R
P V Y N S N K D N Q S E G T A . Q L D S I G F S I I K K C I H A V E T R G I N E Q G L Y R
N Y F G M P L Q D L V T . . . . . A E K P I P L F V E K C V E F I E D T G L C T E G L Y R
S V F G V P L T V N V Q R T . . . . G Q P L P Q S I Q Q A M R Y L R N H C L D Q V G L F R
R V F G C D L G E H L L N S . . . . G F E V P Q V L Q S C T A F I E R Y G I . V D G I Y R
Q Q F G V S L Q H L Q E K N . . P E Q E P I P I V L R E T V A Y L Q A H A L T T E G I F R
P I F G I P L A D A V E R T M M Y D G I R L P A V F R E C I D Y V E K Y G M K C E G I Y R
190 α A0 200 210 α A 220 230
OCRL_2QV2 
p85alpha_1PBW 
p85beta_2XS6 
RhoGAP35_3FK2 
ARHGAP11A_3EAP 
GRAF_BH_1F7C
RhoGAP5_2EE4 
DLC1_3KUQ 
RICS_3IUG 
p50RhoGAP_1RGP
RLIP_188-368 
T P G M Q E E L Q Q I I D C L D T S . . . . . . I P E T I . . . . . P G S N H S V A E A L L I
T Q S S S N L . A E L R Q L L D C D T . . . . . P S V D L E . . . . M I D V H V L A D A F K R
P E L P A P R . . . . . . . . . T D W . . . . . S L S D V D . . . . Q W D T A A L A D G I K S
V S G N K S E M E S L Q R Q F D Q D . . . . . . H N L D L A E K . . D F T V N T V A G A M K S
K S G S V I R L K A L K N K V D H G . . . . . . E G C . L S S . . . A . P P C D I A G L L K Q
I V G V N S R V Q K L L S I L M D P K T A T E T E T E I C A E . . . . W E I K T I T S A L K T
V S G N K T D Q D N I Q K Q F D Q D . . . . . . H N I N L V S M . . E V T V N A V A G A L K A
K S G V K S R I Q A L R Q M N E G A . . . . . . I D C V N Y E . . . G Q S A Y D V A D M L K Q
L S G V A S N I Q R L R H E F D S E . . . . . . H V P D L T K E P Y V Q D I H S V G S L C K L
R S A N T Q V V R E V Q Q K Y N M G . . . . . . L P V D F D Q . . . Y N E L H L P A V I L K T
V S G I K S K V D E L K A A Y D R E . . . . . . E S T N L E D . . . Y . E P N T V A S L L K Q
240 α A1 250 260 α B
OCRL_2QV2 
p85alpha_1PBW 
p85beta_2XS6 
RhoGAP35_3FK2 
ARHGAP11A_3EAP 
GRAF_BH_1F7C
RhoGAP5_2EE4 
DLC1_3KUQ 
RICS_3IUG 
p50RhoGAP_1RGP
RLIP_188-368 
F L E A L P E P V I C Y E L Y Q R C L D S A Y . . . . . . . D P R I C R Q V I S Q . . L P R C
Y L L D L P N P V I P A A V Y S E M I S L A P E V Q S S E E Y I Q L L K K L I R S P S I P H Q
F L L A L P A P L V T P E A S A E A R R A L R E A A G . . . . . . P V G P A L E P P T L P L H
F F S E L P D P L V P Y N M Q I D L V E A H K I . N D R E Q K L H A L K E V L K K . . F P K E
F F R E L P E P I L P A D L H E A L L K A Q Q L . . G T E E K N K A T L L L S C L . . L A D H
Y L R M L P G P L M M Y Q F Q R S F I K A A K L . E N Q E S R V S E I H S L V H R . . L P E K
F F A D L P D P L I P Y S L H P E L L E A A K I . P D K T E R L H A L K E I V K K . . F H P V
Y F R D L P E P L M T N K L S E T F L Q I Y Q Y . V P K D Q R L Q A I K A A I M L . . L P D E
Y F R E L P N P L L T Y Q L Y E K F S D A V S A . A T D E E R L I K I H D V I Q Q . . L P P P
F L R E L P E P L L T F D L Y P H V V G F L N I . . D E S Q R V P A T L Q V L Q T . . L P E E
Y L R D L P E N L L T K E L M P R F E E A C G R . T T E T E K V Q E F Q R L L K E . . L P E C
270 280 α C 290 300 α D 310
OCRL_2QV2 
p85alpha_1PBW 
p85beta_2XS6 
RhoGAP35_3FK2 
ARHGAP11A_3EAP 
GRAF_BH_1F7C
RhoGAP5_2EE4 
DLC1_3KUQ 
RICS_3IUG 
p50RhoGAP_1RGP
RLIP_188-368 
H R N V F R Y L M A F L R E L L K F S E Y N S V N A N M I A T L F T S L L L R P P . . . P N L
Y W L T L Q Y L L K H F F K L S Q T S S K N L L N A R V L S E I F S P M L F R F S . . . A A S
R A L T L R F L L Q H L G R V A R R A P A L G P A V R A L G A T F G P L L L R . A P P P P S S
N H E V F K Y V I S H L N K V S H N N K V N L M T S E N L S I C F W P T L M R P D . . . F S T
T V H V L R Y F F N F L R N V S L R S S E N K M D S S N L A V I F A P N L L Q T S E G H E K M
N R Q M L H L L M N H L A K V A D N H K Q N L M T V A N L G V V F G P T L L R P Q . . . E E T
N Y D V F R Y V I T H L N R V S Q Q H K I N L M T A D N L S I C F W P T L M R P D F E N R E F
N R E V L Q T L L Y F L S D V T A A V K E N Q M T P T N L A V C L A P S L F H L N T L K R E N
H Y R T L E F L M R H L S L L A D Y C S I T N M H A K N L A I V W A P N L L R S K Q I E S A C
N Y Q V L R F L T A F L V Q I S A H S D Q N K M T N T N L A V V F G P N L L W A K . . D A A I
N Y L L I S W L I V H M D H V I A K E L E T K M N I Q N I S I V L S P T V Q I . . . . . . . .
320 α E 330 340 α F 350
OCRL_2QV2 
p85alpha_1PBW 
p85beta_2XS6 
RhoGAP35_3FK2 
ARHGAP11A_3EAP 
GRAF_BH_1F7C
RhoGAP5_2EE4 
DLC1_3KUQ 
RICS_3IUG 
p50RhoGAP_1RGP
RLIP_188-368 
M A R Q T . . . . . . . . . . . P S D R Q R A I Q F L L G F L L G S E
S . . . . . . . . . . . . . D N T E N L I K V I E I L I S T E W N E R
P . P P G G A P D G S E P S P . . D F P A L L V E K L L Q E H L E E .
M . . . . . . . . . . D A L T A T R T Y Q T I I E L F I Q Q C P F F F
S . . . . . . . . . S N T E K K L R L Q A A V V Q T L I D Y A S D I G
V A A I . . . . . . . . . . M D I K F Q N I V I E I L I E N H E K I F
L S T T K . . . . . . . . . . . . . I H Q S V V E T F I Q Q C Q F F F
S S P R V M Q R K Q S L G K P D Q K D L N E N L A A T Q G L A H M I A
F S G T A A F M E V . . . . . . . R I Q S V V V E F I L N H V D V L F
T L K A . . . . . . . . . . . . I N P I N T F T K F L L D H Q G E L F
. . . . . . . . . . . . . . . . . . . S N R V L Y V F F T H V Q E L F
360 α G
Figure 2. Sequence Alignment of RLIP76 with RhoGAP Domains Whose Structures Have Been Solved
The positions of the RLIP76 a helices are denoted as gray cylinders above the alignment and are labeled according to the names of the equivalent helices in the
p50 RhoGAP protein (Barrett et al., 1997). The helical regions in all the proteins are shaded gray and boxed. Residues involved in contacts with Cdc42 aremarked
by circles above the p50 RhoGAP sequence colored as follows: white circles: in contact in the Cdc42$GMPPNP complex (PDB ID code 1AM4); black circles: in
contact in the Cdc42$GDP$AlF3 complex (PDB ID code 1GRN); gray circles: in contact in both complexes. The Arg finger and secondary Lys are marked by black
andwhite triangles, respectively. Residues in the loop between helices aF and aGare shown in white font on a black background if their backbone B factors in the
X-ray structures are more than 20 A˚2 higher than the average or whose coordinates are missing. For the NMR structure of RhoGAP5, residues with a backbone
rmsd of more than 2 A˚ are highlighted in the same manner. The two vertical lines between helices A0 and A mark the position of a large insertion in OCRL, which
has been omitted for clarity. The alignment was generated using T-Coffee (Di Tommaso et al., 2011) and Top3d (Winn et al., 2011) and the figure was produced
using ALSCRIPT (Barton, 1993). The PDB ID codes for the structures are shown after the name of each protein.
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Table 2. Real-Time GAP Assays Recorded on Cdc42 and Rac1
Observed Rate
(min1)
Fold Stimulation
(over Intrinsic)
Rac1 (intrinsic) 0.097 ± 0.0003 –
Rac1 + p50 RhoGAPa 0.404 ± 0.004 4.16
Rac1 + RLIP76 GAPb 0.238 ± 0.0007 2.45
Rac1 + RLIP76 didomainb 0.160 ± 0.0004 1.65
Cdc42 (intrinsic) 0.148 ± 0.001 –
Cdc42 + p50 RhoGAPa 0.490 ± 0.005 3.3
Cdc42 + RLIP76 GAPa 0.425 ± 0.003 2.87
Cdc42 + RLIP76 didomainb 0.304 ± 0.002 2.05
ap50 RhoGAP (25 nM) was added.
bRLIP76 GAP (2.5 mM) and didomain were added.
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Figure 3. Real-Time GAP Assays with RLIP76 and p50 RhoGAP
The intrinsic GTP hydrolysis and the hydrolysis stimulated by p50 RhoGAP,
RLIP76 GAP domain, and the RLIP76 didomain are shown.
(A) GTP hydrolysis by Cdc42.
(B) GTP hydrolysis by Rac1.
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RLIP76 RhoGAP-Ral Binding Domain Dyad Structurein vitro than that of their bona fide GAP, p50 RhoGAP. The
sequence alignments (Figure 2) and structural alignment around
the active site (Figure 1E) show that a conserved pair of basic
residues, the ‘‘arginine finger’’ and the Lys that supports the
position of the arginine finger loop, is present in RLIP76. These
residues are crucial for Ras- and RhoGAP-mediated hydrolysis
reactions and are in the correct position for stimulation of catal-
ysis to be possible in RLIP76. The presence of the linker and
GBD appear to have a slight inhibitory effect on the GAP domain,
which was not relieved by the presence of the GBD binding part-
ner RalB.
Why Does RLIP76 Have Low Catalytic Activity?
As the basic catalytic machinery appears to be present in the
RLIP76 GAP domain, we examined the RLIP76 RhoGAP domain
structure for features that might contribute to its low activity.
Comparison of the sequences of RhoGAP domains whose struc-
tures are known (Figure 2) shows that between helices aF and aG2136 Structure 21, 2131–2142, December 3, 2013 ª2013 The Authorthere is a loop that, in the free RhoGAP proteins, is highly
dynamic. In the free p50 RhoGAP structure, part of the loop is
absent in the structure due to its mobility, whereas in the other
free RhoGAP domain structures there are either missing coordi-
nates or very high temperature factors for residues in the loop. In
RLIP76, the loop is much shorter, as is the N terminus of helix aG
(Figure 2), and our NMR dynamics analysis shows that the three
residues that remain are rigid (data not shown). When p50
RhoGAP forms a complex with Cdc42 and stimulates the
GTPase activity, this loop binds to residues in the switch 2 region
of Cdc42 and becomes rigid (Figure 1F). The essential contacts
between this aF-aG loop of p50 RhoGAP and Cdc42 have been
defined by our previous mutagenesis analysis of the Cdc42-
RhoGAP interaction (Owen et al., 2000, 2008). The residues at
the center of the loop interface, Phe37Cdc42, Tyr64Cdc42, and
Leu67Cdc42, when mutated, reduced the binding 6-fold (F37A),
9-fold (L67A), and >20-fold (Y64A). Mutations of Val36Cdc42
and Leu70Cdc42, which are at the periphery of the loop interface,
do not affect the binding affinity, indicating that although they
make contacts with theGAP domain, they are not thermodynam-
ically essential. These data highlight the importance of the inter-
actions between the switch regions of Cdc42 and the aF-aG loop
of p50 RhoGAP for successful formation of the complex. None
of these contacts can be formed by RLIP76. We therefore
reasoned that the shortened loop in RLIP76 might lead to an
inability of the GAP domain to engage Cdc42 and Rac1, whereas
p50 RhoGAP binds to Cdc42 and Rac1 with affinities of 24 and
18 nM, respectively (Owen et al., 2008). We measured the
binding affinity of RLIP76 GAP for Rac1 and Cdc42 using scintil-
lation proximity assays (SPAs), where His-tagged RLIP76 dido-
main or GAP domain was bound to protein A-coated SPA beads
via an anti-His antibody. An SPA signal is obtained when binding
of His-RLIP76 to Cdc42 (or Rac1)$[3H]GTP occurs. Experiments
were performed using the GTPase-deficient mutants Q61L
Cdc42/Rac1 so that stable [3H]GTP complexes could be
obtained. Affinities were determined for the interactions between
the His-RLIP76 didomain or the His-GAP domain and both
Cdc42 and Rac1. There was no discernable binding between
either Cdc42 or Rac1 with the RLIP76 didomain or the GAP
domain (Figure 4A) even though both G proteins bound to the
positive control, PAK, with affinities of 32 nM (Cdc42) and
57 nM (Rac1), which are similar to values we havemeasured pre-
viously (Owen et al., 2000, 2003).s
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Figure 4. Biochemical Analysis of the RLIP76 GAP Domain and the GAP Insert Mutant
(A) Scintillation proximity assays. The indicated concentrations of [3H]GTP$Rac1 and Cdc42 were incubated with 70 nM His-RLIP76 didomain or GST-PAK1 in
SPAs. The SPA signal was corrected by subtraction of a blank from which the fusion protein was omitted. The effect of the [G protein] on this corrected SPA
counts/min signal was fitted to a binding isotherm to give an apparent Kd value and the signal at saturating concentrations of G protein. The data are expressed as
a percentage of this maximum signal.
(B and C) Competition SPAs. Displacement of (B) [3H]GTP$Cdc42 or (C) [3H]GTP$Rac1 from GST-p50 RhoGAP by RLIP76 constructs or by untagged p50
RhoGAP. Increasing concentrations of RLIP76 or p50 RhoGAP proteins were titrated into fixed concentrations of [3H]GTP$Cdc42 or [3H]GTP$Rac1 and GST-p50
RhoGAP. Fits of the data to a partial competitionmodel for RLIP76GAP or RLIP76 didomain binding toCdc42 (B) or Rac1 (C) are shown. The Kd value for Cdc42 or
Rac1 binding to GST-p50 RhoGAPwas fixed to the values obtained from direct SPAs (80 and 86 nM, respectively). For the RLIP76 GAP insert or p50 RhoGAP, full
competition was used to produce the fits shown. For p50 RhoGAP, the Kd values obtained by competition SPA were 247 ± 30 nM and 150 ± 12 nM for Cdc42 and
Rac1, respectively.
(D) Real-time GAP assays with the RLIP76 GAP insert. The rates of GTP hydrolysis by Cdc42 alone and in the presence of different concentrations of the RLIP76
GAP insert. The integrity of the insert protein was established by gel filtration, western blotting, and circular dichroism (see Figure S1).
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between helices aF and aG in RLIP76 could restore Cdc42 bind-
ing and thus improve RLIP76 GAP activity. Residues Gln351–
Ser353 (Q-I-S) of the RLIP76 GAP domain were replaced by
the equivalent sequence Leu401–Ile416 in p50 RhoGAP (L-W-
A-K-D-A-A-I-T-L-K-A-I-N-P-I). The refolded protein was as-
sessed by circular dichroism and shown to be helical (Figure S1
available online). The binding affinity of the RLIP76 GAP insert for
Cdc42 and Rac1 was measured by competition SPA, which can
measure lower affinities than direct SPA. Proteins were assayed
by binding to Rac1 or Cdc42$[3H]GTP that had been prebound to
GST-tagged, immobilized p50 RhoGAP. We first measured the
binding affinity of RLIP76 GAP and RLIP76 didomain using
competition SPA to quantify the weak affinity of native RLIP76
for Cdc42/Rac1. Interestingly, at saturating concentrations of
RLIP76 RhoGAP domain or RhoGAP-GBD didomain, the signal
did not return to the experimentally determined zero (i.e., the
signal obtained in the absence of GST effector), which would
be expected for a full competitor. The differences observable
between the partial competitors RLIP76 GAP and RLIP76
didomain and a pure competitor, such as free p50 RhoGAP itself,Struare apparent (Figures 4B and 4C). This observation prompted us
to fit the data using an equation describing partial inhibition, in
which the competitor modulates the affinity of the monitored re-
action but does not abolish it completely. In this scenario, even at
saturating levels of RLIP76, there is residual GST-RhoGAP-
Cdc42/Rac1 complex, which gives rise to the SPA signal
observed. The Kd values for RLIP76 GAP and RLIP76 didomain
binding to Cdc42 and Rac1 derived from fitting to a partial
competition model are shown in Table 3. The partial competition
by RLIP76 indicates that the binding surface on Cdc42 and Rac1
for the RLIP76 GAP domain does not fully overlap the binding
surface for the p50 RhoGAP domain. This supports our hypoth-
esis, implying that the aF-aG loop of p50 RhoGAP mediates
some residual binding to Cdc42 and Rac1 even in the presence
of high concentrations of RLIP76 GAP, allowing a ternary
complex to form. In contrast, when the competition assay was
performed using the RLIP76 GAP insert, the signal returned to
the experimentally determined zero at saturating concentrations,
indicating pure competition (Figures 4B and 4C). This implies
that introduction of the longer aF-aG loop results in a larger bind-
ing interface more closely resembling that between Cdc42 andcture 21, 2131–2142, December 3, 2013 ª2013 The Authors 2137
Table 3. Affinities of RLIP76 Constructs for Cdc42 and Rac1
Measured by Competition SPA
Cdc42 (mM) Rac1 (mM)
RLIP76 GAP 6.19 ± 3.35 1.68 ± 0.82
RLIP76 GAP-GBD didomain 5.59 ± 3.58 2.34 ± 1.32
RLIP76 GAP insert 1.27 ± 0.12 1.44 ± 0.25
Figure 5. RLIP76 GAP-GBD Interactions with Ral and Rho Small G
Proteins
(A) The RLIP76 GAP-GBD didomain can simultaneously interact with Ral and
Rho family proteins. The model of the Cdc42$GMPPNP-didomain complex
was superimposed over the RLIP76 GBD onto the RLIP76-RalB complex
structure. Cdc42 is purple-blue, the RLIP76 GAP domain is green, the linker
between the GAP andGBD is cyan, the GBD is in two shades of pink, and RalB
is sky blue. The binding of Cdc42 and RalB together is possible because the
binding sites are on the exterior faces of the two domains that make up the
didomain. The orientation of the two G proteins is such that their C-terminal
helices are pointing toward one side of the trimer and their C-terminal isoprenyl
groups (red) will be able to simultaneously engage the lipid bilayer (gray).
(B) Interactions in the Cdc42$GDP$AlF3-p50 RhoGAP transition-state complex
that would not be conserved in the equivalent complex with RLIP76. The
secondary structures of Cdc42 (purple), RLIP76 GAP (green), and p50
RhoGAP (orange) are semitransparent for clarity. The GDP is shown in a wire-
frame representation, Mg2+ is a dark gray sphere, and AlF3 is a light gray
sphere surrounded by three pale blue spheres. Side chains of Cdc42 and p50
RhoGAP involved in interactions are shown in a stick representation and
colored in the same scheme as the secondary structures. The equivalent
residues in RLIP76 GAP are also shown as sticks.
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the RLIP76 GAP insert than for p50 RhoGAP, it is significantly
higher than for the native RLIP76 GAP protein (Table 3). Interest-
ingly, native RLIP76GAP and didomain bind to Rac1more tightly
than Cdc42 (around 1 mMKd), and the affinity between Rac1 and
the RLIP76 GAP insert was essentially the same (Table 3). As we
do not have a Rac1-p50 RhoGAP structure, it is difficult to spec-
ulate on differences that must exist between the Cdc42-p50
RhoGAP and Rac1-p50 RhoGAP complexes. However, RLIP76
is still a poor GAP for Rac1, despite having some affinity for
this G protein. It is notable that the bona fide RhoGAP, p50
RhoGAP, binds to both Cdc42 and Rac1 with nanomolar affinity.
The RLIP76 GAP insert was then tested in real-time GAP as-
says at low concentrations (25 nM), but it had no effect on the
Cdc42 GAP activity. When higher concentrations of the RLIP76
GAP insert domain were used, close to stoichiometric levels
compared to the Cdc42 concentration, the RLIP76 GAP insert
actually inhibited the GTPase when compared to its intrinsic
rate of hydrolysis (Figure 4D). The intrinsic observed rate was
0.16min1; when 0.4 molar equivalents of the RLIP76 GAP insert
were added the rate decreased to 0.084 min1, and when 0.8
molar equivalents were added the rate decreased to
0.048 min1.
Taken together, these data demonstrate that engineering the
aF-aG loop from p50 RhoGAP into the RLIP76 GAP domain is
sufficient to impart a measurable increase in binding affinity of
RLIP76 GAP for Cdc42. Nevertheless, even this engineered
form of RLIP76 GAP, which binds more tightly to Cdc42, cannot
behave as an efficient GAP. Furthermore, the stabilization of the
Cdc42 switch regions by the aF-aG loop actually inhibits the
GTPase activity when it is present in RLIP76 GAP, presumably
because it binds Cdc42$GTP to form an unproductive complex.
Modeling Protein-Protein Interactions at the Rho-Ras
Signaling Node
Solving the structure of the RLIP76 GAP-GBD didomain allowed
us to construct a model of the tripartite complex that would form
between RLIP76, Cdc42, and RalB. We used the p50 RhoGAP-
Cdc42 structure (PDB ID code 1AM4) to dock Cdc42 to the
RLIP76 GAP domain. The GBD in this model was then superim-
posed onto the GBD in our structure of the RalB-GBD complex
(PDB ID code 2KWI). The resulting complex model (Figure 5A)
shows that the binding of a Rho-family protein and Ral proteins
is not mutually exclusive but rather that simultaneous binding
of two G proteins at the membrane is facilitated by the fixed
orientation of the two domains. This is borne out by our binding
studies that show that the GBD and didomain have the same
affinity for RalB, namely that the presence of the GAP domain
does not affect Ral binding. Even though the GBD is only a small
coiled coil, its interactions with the GAP domain and the linker2138 Structure 21, 2131–2142, December 3, 2013 ª2013 The Authors
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GBD, whereas the interaction with RalB is predominantly with
the C-terminal helix. The only region of the GAP-GBD didomain
that would potentially clash with RalB is the tip of the hairpin
within the linker region. The residues in this hairpin are already
known to be flexible from the NMR dynamics analysis, and
they would therefore be able to move to accommodate the bind-
ing of RalB. The Rho protein binds to a concave surface of the
GAP domain on the opposite face to the GBD, and it would
appear that the presence of GBD should not affect Rho protein
binding at all.
The two G proteins are oriented in the model such that their C
termini are on the same side of the heterotrimer, which has
important potential functional consequences in vivo. The
Cdc42 and RalB complex structures were solved with truncated
proteins, which are therefore not posttranslationally modified, as
they would be in vivo. In both full-length G proteins, the a helix at
the C terminus is followed by a flexible tail with a lipid moiety
attached, which is responsible for membrane attachment.
Cdc42 and RalB in the heterotrimer model are oriented such
that they would be able to be simultaneously membrane bound
via their C termini (Figure 5A). Our model therefore demonstrates
that the tripartite complex would satisfy the restraints imposed
on these proteins in vivo and allow a possible scaffold function
for RLIP76.
DISCUSSION
The structure that we present here describes the only two recog-
nized domains of RLIP76. Due to their respective binding part-
ners, the RhoGAP domain-Ral binding domain dyad represents
the physical point of confluence of Ras and Rho signaling at
RLIP76.
Our structure demonstrates that the RhoGAP domain of
RLIP76 contains the conserved elements that would usually
confer catalytic GTPase activation on the target G proteins.
Despite this, RLIP76, even with respect to those small G proteins
toward which it has some activity, is only a very poor GAP.
To try to understand the molecular basis of the catalytic activ-
ity of RLIP76, we examined other regions of p50 RhoGAP that
contact Cdc42 in the transition-state complex (Nassar et al.,
1998) and are not conserved in RLIP76 (Figure 2). These include
Arg283p50, which forms a weak hydrogen bond with Tyr32Cdc42
and is replaced by Val233 in RLIP76 (Figure 5B). Mutation of
Tyr32Cdc42 can prevent GAP-stimulated hydrolysis of GTP
without reducing binding of Cdc42 and p50 RhoGAP (Fidyk
and Cerione, 2002), suggesting that it is key to the formation of
the transition state. Asn286 and Thr287 of p50 RhoGAP are
replaced by Ile236 and Lys237 in RLIP76. Asn286p50 forms a
hydrogen bond with Glu91Cdc42 in the transition-state complex,
whereas Thr287p50 makes a hydrogen bond with Asn92Cdc42.
The replacement of Asn286p50 by the hydrophobic Ile residue
in RLIP76 is likely to change the interactionwith this region signif-
icantly. The equivalent residues in Graf RhoGAP (Val224 and
Asn225; Figure 2) have been mutated and appear to be involved
in selectivity between different GTPases (Jelen et al., 2009). It
is likely therefore that RLIP76 forms different contacts in the tran-
sition state of the reaction and that this underpins its altered ac-
tivity to Cdc42. Thus, the structure adds to the general body ofStruinformation regarding the action of GAP domains, highlighting
the point that the orientation of side chains important to the tran-
sition state are as important as the canonical catalytic residues.
The structure of the RhoGAP domain of RLIP76 reveals the
truncation of a flexible loop that is involved in substrate binding
in p50 RhoGAP. The absence of this loop goes some way to
explaining the low-level activity of RLIP76 toward Cdc42, as
addition of the loop restores some binding ability for this sub-
strate. However, engineering this loop into the RLIP76 RhoGAP
domain does not elevate GAP activity toward Cdc42 or Rac. It
is possible that the presence of the loop from p50 RhoGAP actu-
ally hinders formation of the correct transition state, because at
high concentrations the RLIP76 mutant with the loop inserted
slightly inhibited the Cdc42 GTPase activity.
This raises the question of the true activity of the RLIP76 GAP
domain in vivo. As all of our work has utilized the isolated
RhoGAP domain or RhoGAP-GBD didomain, it is possible that,
in full-length RLIP76, regions of the protein outside the GAP
domain could contribute residues that impart high-affinity bind-
ing to Cdc42. A second possibility is that the true substrate for
RLIP76 has yet to be identified. Sequence analysis shows that
the Rho protein binding sites on p50 RhoGAP and RLIP76 are
significantly different. As there are 22 members of the Rho family
of GTPases, it would seem likely that the molecular details of
engagement of substrates by RhoGAP domains would be
different, permitting novel modes of substrate engagement by
different RhoGAP domains. Only a systematic analysis of all of
the Rho family members will help us to understand the function
of this domain and identify true substrates. These two possibil-
ities, however, are not mutually exclusive, and we are currently
investigating both. It is also possible that RLIP76 could have
evolved to function as a weak GAP, so that its function is married
to its localization to the membrane by the GBD interacting with
Ral proteins. Thus, it would only be active as a GAP when the
substrate concentration is high or, for example, when the sub-
strate G protein is posttranslationally modified and membrane
attached. This is consistent with in vivo data that show that
Cdc42 is a target for Xenopus laevis RLIP76 (Boissel et al.,
2007) and data in cell lines that show that RNAi knockdown of
RLIP76 leads to increased levels of Cdc42$GTP and Rac1$GTP
(Lim et al., 2010).
A final consideration is that the RLIP76GAP domain could be a
binding module for a different family of GTPases, although as the
main catalytic residues are present and correctly aligned, this
seems unlikely. There is, however, precedence for such a func-
tion, such as the RasGAP domain in IQGAP, which displays no
catalytic activity and has subverted the catalytic domain to utilize
as a binding motif for Rho-family G proteins (Owen et al., 2008),
and OCRL, which contains a nonfunctional RhoGAP domain that
interacts with endocytic adaptors (Pirruccello et al., 2011).
Neither IQGAP nor OCRL contains an Arg finger, but the
RhoGAP domains from the regulatory subunits of the class 1A
PI3 kinases p85a and p85b include both the Arg finger and a sec-
ondary Lys and are still considered to be nonfunctional as GAPs.
The original driver for this work was to determine any influence
these two small G protein binding domains had toward each
other. The structure of the didomain shows that the two domains
are in a fixed orientation with respect to one another. The linker
between them packs between the two domains, fasteningcture 21, 2131–2142, December 3, 2013 ª2013 The Authors 2139
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tion between the two is possible. We therefore first examined the
GAP activity of the RLIP76 GAP domain both alone and within
the context of the didomain. The didomain displays a small
(30%) but reproducible decrease in activity in comparison to
the GAP domain alone. Although it does not seem likely that
such a small decrease would be functionally significant in vivo,
it does show that the RLIP76 GAP domain has the capacity for
slightly higher activity in the absence of the GBD. The GBD
makes no contacts with the catalytic residues in the GAP
domain, so we assume that this influence is a long-range, allo-
steric effect that prevents the subtle rearrangements important
for formation of the transition state of the reaction. We also
examined the effect of the GAP domain on the ability of the
GBD to bind its partner, RalB. The binding affinities of the GBD
and the didomain for RalB are identical, so the ability of the
GBD to bind Ral proteins is unaffected by the presence of the
GAP domain.
As we expected any influence of each domain on the other to
be regulatable, we investigated whether the activity was altered
as a consequence of the presence of binding partners. The GAP
activity of the didomain toward Cdc42 and Rac1 remains unal-
tered in the presence of RalB; that is, binding of RalB to the
GBD does not alleviate the small negative influence of the GBD
on the GAP activity. We cannot exclude the possibility, however,
that the presence of Ral proteinsmight regulate the activity of the
GAP domain toward other, as yet unidentified, Rho-family
proteins.
Thus, it would seem that although the two domains of RLIP76
are both juxtaposed and tethered in a fixed conformation, neither
seems to have a large influence over the known functions of the
other. We therefore conclude that the function of the GBD is to
bind to one of the two Ral isoforms, which then acts to localize
RLIP76 to a particular cellular compartment. At its particular
location it then encounters the relevant substrate for the GAP
domain. Our model of the tripartite complex reveals that the
orientations of the domains would facilitate membrane localiza-
tion by Ral with synchronous binding of Rho-family substrates by
RLIP76.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Human RLIP76 GAP (residues 184–380) and GAP-GBD domains (residues
184–446) were expressed and purified as described previously (Rajasekar
et al., 2012).
The F-G loop from p50 RhoGAP was inserted into the pET16b RLIP GAP
domain construct using site-directed mutagenesis. Residues 351QIS353 of
RLIP76 were replaced with 401LWAKDAAITLKAINPI417 from p50 RhoGAP.
Mutagenesis was performed using a QuikChange Lightning mutagenesis kit
(Agilent), following the manufacturer’s instructions. The RLIP76 GAP domain
with the inserted F-G loop from p50 RhoGAP was expressed in Escherichia
coli BL21 (DE3) in inclusion bodies, which were washed in 2% Triton and
2 M NaCl and solubilized by resuspension in 6 M GuHCl (pH 7.5). The protein
was refolded by rapid, 503 dilution at 4C into 1.5 M 1-(3-sulfopropyl)-pyridi-
nium betaine (Raschig-GmbH), stirred at 4C overnight, concentrated, and
further purified on a 16/60 S75 column.
Mutations of cysteine residues in the GAP-GBD didomain were carried out
using the QuikChange Lightning Multi Site-Directed mutagenesis kit (Agilent)
following the manufacturer’s instructions. Cys216 and Cys227 were mutated
to alanine; Cys291 and Cys313 were mutated to serine.2140 Structure 21, 2131–2142, December 3, 2013 ª2013 The AuthorAll other expression constructs have been described elsewhere (Owen et al.,
2000).
NMR and Structure Generation
All NMR experiments were collected and analyzed as described (Rajasekar
et al., 2012). Backbone torsion angles were estimated from CA, CO, CB, N,
and HA chemical shifts using the program TALOS+ (Shen et al., 2009).
CCPN ANALYSIS (Vranken et al., 2005) was used to generate distance re-
straints from NOESY spectra. Structures were calculated using ARIA 1.2
(Linge et al., 2003) interfaced to CNS (Bru¨nger et al., 1998), where the ambigu-
ity of the restraints was decreased during eight iterations.
Residual dipolar couplings (RDCs) were measured on a Bruker DRX600 by
partially aligning the protein in 13 mg/ml Pf1 phage (Asla Biotech). RDCs
were measured by comparing peak positions in TROSY and decoupled 15N-
HSQC experiments or by using the ARTSY method (Fitzkee and Bax, 2010).
Initial values for the alignment tensors were estimated using a histogram of
the observed dipolar couplings (Clore et al., 1998). The values were refined
with a grid search using a modified version of ARIA 1.2 (Houben et al., 2004;
H.R.M., unpublished data).
PRE restraints were measured using a mutant protein that had a single
cysteine remaining at position 411. MTSSL (1-oxyl-2,2,5,5-tetramethylpyrro-
line-3-methyl) methanethiosulfonate; Enzo LifeSciences) was attached to
Cys411 by incubating the 15N-labeled protein with 20 mMMTSSL at 4C over-
night in 20 mM Tris-HCl (pH 7.9) and 100 mM NaCl. MTSSL loading was
confirmed by mass spectrometry. 15N-TROSY HSQC spectra were recorded
on unlabeled and MTSSL-labeled protein. Cross-peak intensities were
measured, and the ratios were used to generate distance restraints (Battiste
and Wagner, 2000) between 16 and 23 A˚ with errors of ±10 A˚. Cross-peaks
that had disappeared in the MTSSL-labeled spectra were restrained to 16 A˚
with no lower bound and the upper bound set to 26 A˚.
In Vitro GAP Assays
Rac1 and Cdc42 were GTP loaded by incubation in a 103 molar excess of
GTP, 60 mM ammonium sulfate, 20 mM EDTA, 20 mM Tris-HCl (pH 7.4),
and 50 mM NaCl for 1 min at 37C. Then the mixture was briefly incubated
on ice and MgCl2 was added to 100 mM. The reaction mixture was passed
through a G25 spin column to remove excess GTP and used immediately in
the assays. The release of phosphate from Rac1 or Cdc42 was monitored at
360 nm using the EnzChek phosphate assay kit (Invitrogen) to quantify inor-
ganic phosphate released in the reaction. The GAP activities of the RLIP76
didomain, RLIP76 GAP domain, and the GAP domain from p50-RhoGAP to-
ward wild-type Rac1 (25 mM) and wild-type Cdc42 (25 mM) were monitored
simultaneously on amicroplate spectrophotometer (Spectra Max Plus; Molec-
ular Devices). All experiments were performed at 25C in 50 mM Tris-HCl
(pH 7.5), 10 mM NaCl, and 1 mM MgCl2.
Scintillation Proximity Assays
Direct Binding SPAs
Affinities of Rac1 and Cdc42 for His-RLIP76 GAP or His-RLIP76 didomain
were measured using SPAs, in which the fusion protein was attached to a flu-
oromicrosphere via an anti-His antibody (Sigma) in the presence of Q61L
Rac1/Cdc42$[3H]GTP. Binding of the G protein to the His-RLIP76 constructs
brings the labeled nucleotide close enough to the scintillant to obtain a signal.
Apparent Kds for Q61L Rac1/Cdc42$[
3H]GTP were measured as described
previously (Thompson et al., 1998) by varying the concentration of Rac1/
Cdc42$[3H]GTP at a constant concentration of 70 nM His-RLIP76. Using this
method, the upper and lower limits of the Kd that can accurately be measured
are 1,000 and 1 nM, respectively. For each affinity determination, data points
were obtained for at least ten different Rac1/Cdc42 concentrations. Binding
curves were fitted using the appropriate binding isotherms to obtain Kd values
and their standard errors (Thompson et al., 1998). The integrity of the Rac1/
Cdc42$[3H]GTP proteins was checked using GST-PAK as a control binding
partner as described previously (Owen et al., 2000).
Competition SPAs
For competition assays, His-RLIP76 GAP, His-RLIP76 GAP-GBD didomain,
His-RLIP76 GAP insert, or free RhoGAP was titrated into a mixture of 30 nM
[3H]GTP,Rac1 or [3H]GTP,Cdc42 and 30 nM GST-p50 RhoGAP immobilized
on fluoromicrospheres via an anti-GST antibody (Invitrogen). The addeds
Structure
RLIP76 RhoGAP-Ral Binding Domain Dyad StructureRLIP76 or free p50 RhoGAP proteins compete with the GST-p50 RhoGAP-[3H]
GTP,Rac1/Cdc42 interaction, abolishing the scintillation signal. The highest
concentrations of competitor used were RhoGAP, 16 mM; His-RLIP76 GAP,
31.25 mM; His-RLIP76 didomain, 27.3 mM; and His-RLIP76 GAP insert,
17.5 mM. In each case, a blank was performed in the absence of GST-p50
RhoGAPGBD. For affinity determination, data points were obtained for at least
ten different competitor concentrations. The Kd value and its standard errors
were obtained by fitting the dose-response curve to binding isotherms that
describe competition between two proteins binding to one site on another pro-
tein and account for mutual depletion of the interacting components. The Kd
values for the GST-p50 RhoGAP-Rac1/Cdc42 interactions were obtained
from direct-binding SPAs (Fenwick et al., 2009). The equations used were
adapted for SPA from the previously published derivations (Wang, 1995) and
have been fully described elsewhere (Elliot-Smith et al., 2007).
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